Represents private equity institutions and multinational private and public companies in all aspects of corporate tax matters.
Natasha's practice has a focus on the technology and life sciences sectors.
Natasha Kaye has a broad corporate tax advisory and transactional practice, with a particular focus on private equity (advising both institutions and management teams) and working extensively with clients in the technology and the life sciences sectors, with businesses at all stages of growth.
More generally, she advises on a range of transactions, including cross-border and domestic M&A, equity capital markets transactions, reorganizations, joint ventures, restructurings, financing transactions and international tax planning.
Representative Work
Advising the management team of Adenza software provider to the financial services sector on its $10 billion sale to Nasdaq.
Advising Susquehanna Private Capital on its acquisition of a global leader in interpretation and translation technology, thebigword Group.
Advising Snap Inc. on its acquisition of Wave Optics, a display technology company, for in excess of $500 million.
Advising global insights technology provider Toluna Holdings on its acquisition of US business GutCheck and subsequent acquisition of market research and insights leader MetrixLab.
Advising the management team of software provider Calypso Technology Inc. on the sale of Calypso to private equity firm Thoma Bravo.
Advising Pizza Hut Restaurants UK and its senior leadership team on the management buyout of the business and in relation to its subsequent company voluntary arrangement.
Advising Primary Capital on its significant investment in Sigma Sports, the UK's leading premium omnichannel retailer of cycling equipment.
Advised Autolus on its strategic collaboration with BioNTech to advance both companies' autologous CAR-T programs toward commercialization, as well as a $350 million underwritten offering.
Advised 2C2P, a global payments platform, on its strategic partnership with Ant Group, an innovative technology provider that strives to bring the world inclusive, green and sustainable services.
Advised Bavarian Nordic on its agreement to acquire the manufacturing and global rights to two commercial vaccines - Rabipur/RabAvert and Encepur - from GlaxoSmithKline, for €796 million.
Read Less
Education
LL.M., Queen Mary, University of London, 2001
L.P.C., The College of Law, London, 1997
B.A., University of Leeds, 1996
Bar Admissions
Solicitor, England and Wales
Recognitions
The Legal 500, London: Corporate Tax.
Chambers & Partners (UK, Europe, Global): Tax.
Business Today: Top 10 Influential UK Tax Lawyers: Expertise in Business Transactions, 2023.
